Plain-English translation of NCT07320560 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a personalized approach to treating persistent atrial fibrillation (a condition where your heart's upper chambers beat irregularly). Instead of using a standard one-size-fits-all approach, doctors will use advanced non-invasive mapping technology to identify which specific areas of your heart are causing the irregular rhythm, then target those areas during a catheter ablation procedure.
Many patients with persistent atrial fibrillation don't fully benefit from the standard ablation procedure alone. This trial explores whether using advanced mapping technology to personalize the treatment can better identify and treat the specific sources driving the irregular heartbeat.
You likely qualify if…
You likely don't qualify if…
You would undergo a catheter ablation procedure that includes two main steps: first, the standard pulmonary vein isolation (the current treatment approach), and second, a personalized ablation targeting up to three additional heart regions identified by advanced non-invasive mapping. The mapping technology will have been used before your procedure to identify which specific areas of your heart are driving the irregular rhythm. The trial will track how well this approach works and whether it safely improves outcomes compared to the standard approach alone.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Germany
Portugal
Spain